137 related articles for article (PubMed ID: 9124807)
21. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
McCord JM
Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
[No Abstract] [Full Text] [Related]
22. Increased superoxide dismutase activity improves survival of cultured postnatal midbrain neurons.
Przedborski S; Khan U; Kostic V; Carlson E; Epstein CJ; Sulzer D
J Neurochem; 1996 Oct; 67(4):1383-92. PubMed ID: 8858919
[TBL] [Abstract][Full Text] [Related]
23. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
24. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.
Ripps ME; Huntley GW; Hof PR; Morrison JH; Gordon JW
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):689-93. PubMed ID: 7846037
[TBL] [Abstract][Full Text] [Related]
25. Autoradiographic distribution of mu opioid receptors in the brains of Cu/Zn-superoxide dismutase mice.
Kujirai K; Carlson E; Epstein CJ; Cadet JL
Synapse; 1994 Jun; 17(2):76-83. PubMed ID: 8091304
[TBL] [Abstract][Full Text] [Related]
26. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations.
Przedborski S; Dhawan V; Donaldson DM; Murphy PL; McKenna-Yasek D; Mandel FS; Brown RH; Eidelberg D
Neurology; 1996 Dec; 47(6):1546-51. PubMed ID: 8960743
[TBL] [Abstract][Full Text] [Related]
27. Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model.
Yang EJ; Jiang JH; Lee SM; Hwang HS; Lee MS; Choi SM
J Neuroimmunol; 2010 Jun; 223(1-2):84-91. PubMed ID: 20460191
[TBL] [Abstract][Full Text] [Related]
28. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
Gurney ME; Cutting FB; Zhai P; Doble A; Taylor CP; Andrus PK; Hall ED
Ann Neurol; 1996 Feb; 39(2):147-57. PubMed ID: 8967745
[TBL] [Abstract][Full Text] [Related]
29. The roles of free radicals in amyotrophic lateral sclerosis.
Liu D
J Mol Neurosci; 1996; 7(3):159-67. PubMed ID: 8906612
[TBL] [Abstract][Full Text] [Related]
30. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity.
Dentel C; Palamiuc L; Henriques A; Lannes B; Spreux-Varoquaux O; Gutknecht L; René F; Echaniz-Laguna A; Gonzalez de Aguilar JL; Lesch KP; Meininger V; Loeffler JP; Dupuis L
Brain; 2013 Feb; 136(Pt 2):483-93. PubMed ID: 23114367
[TBL] [Abstract][Full Text] [Related]
31. Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation.
Geracitano R; Paolucci E; Prisco S; Guatteo E; Zona C; Longone P; Ammassari-Teule M; Bernardi G; Berretta N; Mercuri NB
Neuroscience; 2003; 118(2):399-408. PubMed ID: 12699776
[TBL] [Abstract][Full Text] [Related]
32. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.
Yim MB; Kang JH; Yim HS; Kwak HS; Chock PB; Stadtman ER
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5709-14. PubMed ID: 8650157
[TBL] [Abstract][Full Text] [Related]
33. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study on the aggregation of ubiquitin in the central nervous system of the transgenic mice expressing a human Cu/Zn SOD mutation.
Chung YH; Joo KM; Lee YJ; Kim MJ; Cha CI
Neurol Res; 2003 Jun; 25(4):395-400. PubMed ID: 12870267
[TBL] [Abstract][Full Text] [Related]
35. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice.
Pedersen WA; Mattson MP
Brain Res; 1999 Jun; 833(1):117-20. PubMed ID: 10375685
[TBL] [Abstract][Full Text] [Related]
36. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis.
Dal Canto MC; Gurney ME
Am J Pathol; 1994 Dec; 145(6):1271-9. PubMed ID: 7992831
[TBL] [Abstract][Full Text] [Related]
37. Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis.
Wolf HK; Crain BJ; Siddique T
Clin Neuropathol; 1991; 10(6):291-6. PubMed ID: 1764852
[TBL] [Abstract][Full Text] [Related]
38. Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.
Bergeron C; Petrunka C; Weyer L
Am J Pathol; 1996 Jan; 148(1):273-9. PubMed ID: 8546216
[TBL] [Abstract][Full Text] [Related]
39. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Tanase K; Teng Q; Krishnaney AA; Liu JK; Garrity-Moses ME; Boulis NM
J Neurosurg Spine; 2004 Jul; 1(1):128-36. PubMed ID: 15291033
[TBL] [Abstract][Full Text] [Related]
40. Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD.
Shibata N; Hirano A; Kobayashi M; Dal Canto MC; Gurney ME; Komori T; Umahara T; Asayama K
Acta Neuropathol; 1998 Feb; 95(2):136-42. PubMed ID: 9498047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
